SCHEMBL1933231

SCHEMBL1933231

CCc1ccc[c]c1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9359703 0.83 GABRA1 (0.37)
SCHEMBL6222948 0.79 TYR (0.43)
SCHEMBL5504187 0.79
SCHEMBL9174076 0.78 LIPG (0.49)
SCHEMBL11731891 0.77
SCHEMBL6762396 0.77 AKR1B1 (0.55)
SCHEMBL4563689 0.77 GABRA1 (0.55)
SCHEMBL5271616 0.77 LIPG (0.51)
SCHEMBL5269202 0.77 LIPG (0.51)
SCHEMBL5269770 0.77 LIPG (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024040799-A1 USE OF REYANNING IN PREPARATION OF DRUG FOR TREATING SARS-COV-2 ASYMPTOMATIC OR MILD INFECTION IN CHILDREN OR ADOLESCENTS 清华德人西安幸福制药有限公司 2024-02-29 WO claimed
WO-2006002022-A2 COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF HYPERGLYCEMIA IMMUSOL INCORPORATED (US) 2006-01-05 WO claimed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US claimed
EP-1487792-A1 DIHYDROINDOL-2-ONE DERIVATIVES AS STEROID HORMONE NUCLEAR RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2004-12-22 EP claimed
WO-2003078394-A1 DIHYDROINDOL-2-ONE DERIVATIVES AS STEROID HORMONE NUCLEAR RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2003-09-25 WO claimed
EP-0605951-B1 A nail lacquer composition EDGE BIOSYSTEMS INC (US) 1999-06-30 EP claimed
EP-0605951-A1 A nail lacquer composition ADVANCED GENETIC TECHNOLOGIES CORPORATION (US) 1994-07-13 EP claimed
JP-61105544-A None JP disclosed
WO-2024016630-A1 PHARMACEUTICAL COMPOSITION OF DILTIAZEM HYDROCHLORIDE, PREPARATION METHOD, AND USE THEREOF 上海奥全生物医药科技有限公司 2024-01-25 WO disclosed
WO-2023182327-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, ORGANIC EL DISPLAY DEVICE, AND METHOD FOR PRODUCING CURED PRODUCT 東レ株式会社 2023-09-28 WO disclosed
CN-115698854-A Photosensitive resin composition, cured product, display device, semiconductor device, and method for producing cured product 东丽株式会社 2023-02-03 CN disclosed
CN-105068389-A Electrophotographic photoreceptor, electrophotographic photoreceptor cartridge, and image forming apparatus MITSUBISHI CHEM CORP 2015-11-18 CN disclosed
CN-102163013-B Electrophotographic photoreceptor and image forming apparatus using the same MITSUBISHI CHEM CORP 2015-02-18 CN disclosed
US-5086173-A Hydrogenating in presence of palladium catalyst without isolating the intermediates CIBA-GEIGY CORPORATION (US) 1992-02-04 US disclosed
EP-0457730-A2 Process for preparation of thioderivatives of alkylhydroxyanilinotriazine CIBA-GEIGY AG (CH) 1991-11-21 EP disclosed
US-5017703-A Antiallergens, antiinflammatory FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-05-21 US disclosed
US-4935432-A ANTIALLERGENS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-06-19 US disclosed
EP-0324431-A1 New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-07-19 EP disclosed
US-4734504-A 1-alkylated diazolidinones ELI LILLY AND COMPANY (US) 1988-03-29 US disclosed
JP-S61105544-A PATTERN FORMING MATERIAL AND FORMATION OF PATTERN NIPPON TELEGR & TELEPH CORP <NTT> 1986-05-23 JP disclosed